| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.092 | 0.05 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.061 | 0.05 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.098 | 0.05 |